| Dr Eddy Lloyd Caldwell, DPM | |
|
406 E Washington Ave, Jonesboro, AR 72401-3108 | |
| (870) 933-8900 | |
| (870) 933-2611 |
| Full Name | Dr Eddy Lloyd Caldwell |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 406 E Washington Ave, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235131640 | NPI | - | NPPES |
| 130246748 | Other | AR | CLINIC NUMBER |
| 167681748 | Other | AR | MEDICAID CLINIC |
| 130109717 | Medicaid | AR | |
| 5T344F963 | Other | AR | MEDICARE CLLINIC |
| 480034780 | Other | AR | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | AR-163 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Bernards Medical Center | Jonesboro, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foot Care Of Northeast Arkansas Pa | 0143309153 | 2 |
News Archive
A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces pain levels during treatment of basal cell carcinoma (BCC), while achieving efficacy comparable with a hospital stay. These findings come from a breakthrough pilot study, presented today at the 30th EADV Congress.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection.
Cedars-Sinai Medical Center has launched a Phase I clinical trial to study the safety and tolerability of an experimental immunization to treat Alzheimer's disease. The treatment is based on Copaxone (glatiramer acetate), a drug often prescribed to reduce the frequency of multiple sclerosis relapses.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
› Verified 8 days ago
| Provider Name | Foot Care Of Northeast Arkansas Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750550489 PECOS PAC ID: 0143309153 Enrollment ID: O20080501000689 |
News Archive
A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces pain levels during treatment of basal cell carcinoma (BCC), while achieving efficacy comparable with a hospital stay. These findings come from a breakthrough pilot study, presented today at the 30th EADV Congress.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection.
Cedars-Sinai Medical Center has launched a Phase I clinical trial to study the safety and tolerability of an experimental immunization to treat Alzheimer's disease. The treatment is based on Copaxone (glatiramer acetate), a drug often prescribed to reduce the frequency of multiple sclerosis relapses.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eddy Lloyd Caldwell, DPM Po Box 1984, Jonesboro, AR 72403-1984 Ph: (870) 933-8900 | Dr Eddy Lloyd Caldwell, DPM 406 E Washington Ave, Jonesboro, AR 72401-3108 Ph: (870) 933-8900 |
News Archive
A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces pain levels during treatment of basal cell carcinoma (BCC), while achieving efficacy comparable with a hospital stay. These findings come from a breakthrough pilot study, presented today at the 30th EADV Congress.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection.
Cedars-Sinai Medical Center has launched a Phase I clinical trial to study the safety and tolerability of an experimental immunization to treat Alzheimer's disease. The treatment is based on Copaxone (glatiramer acetate), a drug often prescribed to reduce the frequency of multiple sclerosis relapses.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
› Verified 8 days ago
Family Foot & Ankle Center Podiatrist Medicare: Medicare Enrolled Practice Location: 1000 Windover, Suite A, Jonesboro, AR 72401 Phone: 870-934-8200 Fax: 870-934-8219 | |
Podiatry Group The Foot Doctors Ltd Podiatrist Medicare: Medicare Enrolled Practice Location: 637 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-931-3338 Fax: 870-935-9084 | |
Christopher Rowlett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4802 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-934-3633 | |
Dr. Lee Paul Woodruff, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1815 Executive Sq, Jonesboro, AR 72401 Phone: 870-933-0041 Fax: 870-933-0531 | |
Dr. Walter Wadsworth Hayes, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1000 Windover, Suite A, Jonesboro, AR 72401 Phone: 870-934-8200 Fax: 870-934-8219 | |
Dr. William George Coates Jr., D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 637 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-931-3338 Fax: 870-935-9084 |